Prothena (PRTA)
(Delayed Data from NSDQ)
$21.19 USD
+0.32 (1.53%)
Updated Apr 29, 2024 03:59 PM ET
After-Market: $21.20 +0.01 (0.05%) 7:54 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Brokerage Reports
Prothena Corporation plc [PRTA]
Reports for Purchase
Showing records 161 - 180 ( 329 total )
Company: Prothena Corporation plc
Industry: Medical - Biomedical and Genetics
Company: Prothena Corporation plc
Industry: Medical - Biomedical and Genetics
MORNING CALL
Provider: WEDBUSH SECURITIES INC.
Company: Prothena Corporation plc
Industry: Medical - Biomedical and Genetics
Downgrading to NEUTRAL; VITAL Delay Diminishes Risk/ Reward Equation
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Prothena Corporation plc
Industry: Medical - Biomedical and Genetics
Company: Prothena Corporation plc
Industry: Medical - Biomedical and Genetics
Company: Prothena Corporation plc
Industry: Medical - Biomedical and Genetics
HEALTHCARE - The Week Ahead in Life Sciences
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Prothena Corporation plc
Industry: Medical - Biomedical and Genetics
Company: Prothena Corporation plc
Industry: Medical - Biomedical and Genetics
PRX003 to Not Be Advanced, Valuation Thesis Unchanged
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Prothena Corporation plc
Industry: Medical - Biomedical and Genetics
MORNING CALL
Provider: WEDBUSH SECURITIES INC.
Company: Prothena Corporation plc
Industry: Medical - Biomedical and Genetics
Company: Prothena Corporation plc
Industry: Medical - Biomedical and Genetics
Company: Prothena Corporation plc
Industry: Medical - Biomedical and Genetics
Company: Prothena Corporation plc
Industry: Medical - Biomedical and Genetics
Company: Prothena Corporation plc
Industry: Medical - Biomedical and Genetics
Start of Parkinsons Trial and Amyloidosis Enrollment, Psoriasis Update Ahead
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Prothena Corporation plc
Industry: Medical - Biomedical and Genetics
MORNING CALL
Provider: WEDBUSH SECURITIES INC.
Company: Prothena Corporation plc
Industry: Medical - Biomedical and Genetics
The Week Ahead in Life Sciences: Upcoming Events for the Week of Aug 7
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Prothena Corporation plc
Industry: Medical - Biomedical and Genetics
Company: Prothena Corporation plc
Industry: Medical - Biomedical and Genetics
Company: Prothena Corporation plc
Industry: Medical - Biomedical and Genetics
Company: Prothena Corporation plc
Industry: Medical - Biomedical and Genetics
1Q, Overenrollment in PRONTO and VITAL Indicates Strong Patient Interest in NEOD001, Reiterate OP, PT Trim to $75
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D